Aims Statin intolerance (SI) represents a significant public health problem for which precise
estimates of prevalence are needed. Statin intolerance remains an important clinical …

Aims To update the evidence about the diabetogenic effect of statins. Methods We searched
for randomized-controlled trials reporting the effects of statin therapy on glycosylated …

Background: Current guidelines call for high-intensity statin therapy in patients with
cardiovascular disease on the basis of several previous “more versus less statins” trials …

In Taiwan, the prevalence of hyperlipidemia increased due to lifestyle and dietary habit
changes. Low density lipoprotein cholesterol (LDL-C) and non-high density lipoprotein …

Abstract The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, or
statins, are administered as first line therapy for hypercholesterolemia, both in primary and …

Objective To compare the efficacy of different statin treatments by intensity on levels of non-
high density lipoprotein cholesterol (non-HDL-C) for the prevention of cardiovascular …

Aims Whether adverse effect of statins on glycaemic indices is common to all statins remains
controversial and as yet data for pitavastatin are limited. We sought to assess the effects of …

Aims/hypotheses Current evidence indicates that statins increase the risk of incident
diabetes; however, the relationship between statins and glycaemic control in people with …

Background The efficacy and safety of ticagrelor compared with clopidogrel in acute
coronary syndrome has not previously been evaluated in an Eastern Asian population …

Background Pitavastatin is the newest statin on the market, and the dose‐related magnitude
of effect of pitavastatin on blood lipids is not known. Objectives Primary objective To quantify …